Among teens aged 15-19 years attending Title X clinics, LARC use increased from 0.4% in 2005 to 7.1% in 2013, reports the Centers for Disease Control and Prevention. Why not higher? Commonly cited barriers include cost (60%), staff concerns about IUD use among teens (47%), and lack of training on insertion of implants (47%) and IUDs (38%).
Media headlines recently carried news on a study reporting that ever use of hormonal contraception was associated with a 50 percent increased risk of glioblastoma multiforme, a deadly form of cancer responsible for 80% of brain tumors. Just what was this study about and how do we put it into perspective?
The US Medical Eligibility Criteria for Contraceptive Use (US MEC) provides clinical guidance for safe use of contraceptive methods by women and men with various characteristics and medical conditions, with over 1800 recommendations pertaining to more than 60 conditions. The Centers for Disease Control and Prevention (CDC) has developed several user-friendly tools to help providers access this guidance in the clinic setting.
The “Contraceptive Technology” conferences will help you synthesize the data and translate the evidence into clinical “pearls” you can put directly into practice. With an array of Preconferences delving into selected specialty areas of interest, plenary sessions focusing on the “hottest” topics, a thought-provoking luncheon presentation, and 30 dynamic, interactive Concurrent Sessions, including hands-on workshops…this conference is certain to improve your clinical practice and expand your network of colleagues. Read more